You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
20 August 2021
Johnson & Johnson (J&J) has announced that Alex Gorsky is stepping down as chief executive officer after nearly a decade in the role. Gorsky said the move was due to “family health reasons”.
23 July 2021
Johnson & Johnson (J&J) expects to see “more normalised growth” in the second half of 2021 as “consumers return to typical usage patterns”.
17 June 2021
The US Consumer Healthcare Products Association (CHPA) has elected Johnson & Johnson’s (J&J’s) Michelle Wang Goodridge as the new chair of its board of directors. She is the industry association’s first female chair.
23 April 2021
Johnson & Johnson (J&J) reported a double-digit drop in its OTC sales during the first quarter of 2021, as the COVID-19 pandemic took its toll in multiple ways.
29 January 2021
Worldwide sales at Johnson & Johnson’s (J&J’s) OTC business declined in the fourth quarter of 2020 as measures to control the COVID-19 pandemic meant fewer people suffered from coughs, colds and flu.
20 November 2020
Johnson & Johnson’s Benacort Hayfever Relief – containing the intranasal corticosteroid budesonide – has been switched to general-sales list (GSL) status in the UK.
16 October 2020
Johnson & Johnson’s (J&J’s) OTC business reported strong sales growth in the US in the third quarter of 2020 but international sales experienced a significant fall.
28 September 2020
Johnson & Johnson’s (J&J’s) Consumer Health division is investing USD800 million between now and 2030 to “make its products more sustainable for a healthier planet”.
20 July 2020
Johnson & Johnson’s (J&J’s) OTC sales in the US increased by almost a third in the second quarter of 2020 amid the COVID-19 pandemic. However, the US-based company’s international OTC sales dropped by 5.0% on an operational basis.
21 May 2020
Johnson & Johnson (J&J) Consumer Health has discontinued talc-based Johnson’s Baby Powder in the US and Canada, but will continue selling the product in other markets around the world.